Elucid Bioimaging Inc.
BOSTON, MA · Founded 2013 · CIK 0001585931 · Medtech · Private
vascuCAP, image analysis software that quantifies coronary plaque morphology and rupture risk from CT angiography scans
elucid.com →- Grants
- $1.6M
- 1 award
- Sector median: 1
- Raised
- $116M
- 3 Form D · Oct 2025
- 11 months since last filing
- Contracts
- $151K
- 5 awards · Health and Human S, Defense
- #480 of 4531 in medtech
- Patents
- 25
- 11 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $375,000 | |
| Federal grant | Department of Health and Human Services · Phase II · vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy | $1,581,871 | |
| Federal contract | Department of Health and Human Services · Elucid Bioimaging Vascucap Software License | $30,000 | |
| Federal contract | Department of Health and Human Services · Elucid Bioimaging Vascucap License | $30,000 | |
| Federal contract | Department of Health and Human Services · Elucid Bioimaging Vascucap License | $30,000 | |
| Federal contract | Department of Health and Human Services · Coronary Computed Tomography Angiography (ccta)-based Arteries Phenotype In Humans | $30,000 | |
| Federal contract | Department of Defense · Software Licenses | $31,153 | |
| Private capital raised | Form D · SEC | $78,950,836 | |
| Private capital raised | Form D · SEC | $36,495,008 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 477 | iRhythm Technologies, Inc. | $163K | $59M |
| 478 | ProNova Solutions, LLC | $161K | $40M |
| 479 | Glaukos Corporation | $160K | $76M |
| 480 | Elucid Bioimaging Inc. | $151K | $116M |
| 481 | ENDECTRA LLC | $150K | — |
| 482 | SPECTRAL MOLECULAR IMAGING, INC. | $150K | — |
| 483 | MICROHORTONE LLC | $150K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert BraunDirector
- Andrew BucklerExecutive Officer
- Shamiram FeinglassDirector
- Kelly HuangDirector · Executive Officer
- Scott HuennekensDirector · Executive Officer
- Richard KuntzDirector
- Michael LeshDirector
- Evan MelroseDirector
- Rajesh PandaDirector
- Blake RichardsDirector · Executive Officer
Patents
- Characterizing Permeability, Neovascularization, Necrosis, Collagen Breakdown, Or Inflammationapplication
- Characterizing Permeability, Neovascularization, Necrosis, Collagen Breakdown, Or Inflammationgranted
- Systems And Methods For Diagnostics For Management Of Cardiovascular Disease Patientsapplication
- Structured Representations For Interpretable Machine Learning Applications In Medical Imagingapplication
- Determining Biological Properties Of Atherosclerotic Plaque, Coronary Artery Disease, Or Vasculopathygranted
- Progressive Exploitation Of Multi-energy And Photon Counting Modalitiesapplication
- Structured Representations For Interpretable Machine Learning Applications In Medical Imaginggranted
- Myocardial Ischemia Predictiongranted
- Combined Assessment Of Morphological And Perivascular Disease Markersapplication
- Non-invasive Imaging To Inform Patient Caregranted
- Non-invasive Imaging To Determine Health And Diseasegranted
- Longitudinal Change Measures For Optimizing Patient Caregranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.